Clinical Trial Update: A Phase I Study of YK012 in Primary Membranous Nephropathy [Phase 1]

View source ↗

Summary

Phase I clinical trial of YK012 for primary membranous nephropathy; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• YK012

Snippet

Sponsor: Excyte Biopharma Ltd | Conditions: Primary Membranous Nephropathy | Phase 1 | Status: NOT_YET_RECRUITING